Genotyping of Clinical Parameters in Age-Related Macular Degeneration
- PMID: 35241908
- PMCID: PMC8888136
- DOI: 10.2147/OPTH.S318098
Genotyping of Clinical Parameters in Age-Related Macular Degeneration
Abstract
Background: Optical coherence tomography (OCT) parameters like subretinal fluid (SRF), intra retinal fluid (IRF) and retinal detachment (RPED) etc are routinely accessed by ophthalmologists in patients with retinal complaints. Correlation of OCT findings with genotype and phenotype of AMD patients is relatively unexplored. Here, we have investigated the association of OCT parameters' with genetic variants along with protein expressions and examined their clinical relevance with AREDS (Age-Related Eye Disease Study) criteria in AMD patients.
Methods: For this study, samples were recruited from Advanced Eye Centre, PGIMER, Chandigarh, India. Case-only analysis of anonymous imaging data (OCT/Fundus) acquired during the routine clinical evaluation of patients was done to examine the OCT findings in the AMD patients. TaqMan genotyping assays were used to analyze the single nucleotide polymorphisms in these patients. ELISA (enzyme linked immunosorbent assay) was used to estimate the protein levels of these genes in serum. Information pertaining to lifestyle/habits was also collected by administering a standard questionnaire at the time of recruitment of the patients.
Results: Intra-retinal fluid (IRF) was associated significantly with the LIPC genotype (p=0.04). Similarly, smoking status and early AMD were also associated with the APOE genotype (p=0.03). Additionally, variants of IER-3 and SLC16A8 were also found to be associated with co-morbidities (p=0.02) and males (p=0.02), respectively. RPED has shown a significant association with AREDS criteria, which demonstrated an area under AUROC around 72%.
Conclusion: Results of genotype-phenotype association can give a precise impression of AMD severity and can be beneficial for the early diagnosis of AMD cases.
Keywords: APOE; AREDS; HTRA1; IPC; OCT parameters; RPE detachment; TIMP-3; age-related macular degeneration; anti-VEGF therapy.
© 2022 Battu et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.Ophthalmol Retina. 2021 Oct;5(10):954-961. doi: 10.1016/j.oret.2021.05.009. Epub 2021 May 19. Ophthalmol Retina. 2021. PMID: 34022443
-
The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration--a phase IV randomised clinical trial with ranibizumab: the FLUID study.BMC Ophthalmol. 2016 Mar 24;16:31. doi: 10.1186/s12886-016-0207-3. BMC Ophthalmol. 2016. PMID: 27009515 Free PMC article. Clinical Trial.
-
Modulated anti-VEGF therapy under the influence of lipid metabolizing proteins in Age related macular degeneration: a pilot study.Sci Rep. 2022 Jan 13;12(1):714. doi: 10.1038/s41598-021-04269-6. Sci Rep. 2022. PMID: 35027571 Free PMC article.
-
Defining response to anti-VEGF therapies in neovascular AMD.Eye (Lond). 2015 Jun;29(6):721-31. doi: 10.1038/eye.2015.48. Epub 2015 Apr 17. Eye (Lond). 2015. PMID: 25882328 Free PMC article. Review.
-
Photodynamic therapy for polypoidal choroidal vasculopathy.Prog Retin Eye Res. 2013 Nov;37:182-99. doi: 10.1016/j.preteyeres.2013.09.003. Epub 2013 Oct 15. Prog Retin Eye Res. 2013. PMID: 24140257 Review.
Cited by
-
Electrically-evoked responses for retinal prostheses are differentially altered depending on ganglion cell types in outer retinal neurodegeneration caused by Crb1 gene mutation.Front Cell Neurosci. 2023 Feb 6;17:1115703. doi: 10.3389/fncel.2023.1115703. eCollection 2023. Front Cell Neurosci. 2023. PMID: 36814867 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous